Search
for
Sort by
Research 421–450 of 1000+
- A Systematic Scoping Review and Conceptual Analysis of New-Onset Fibromyalgia Manifestations After Non-Hospitalized COVID-19: Empirics, Definitions, Methodologies, Pathophysiology, Mapping of Literature, and Knowledge Gaps
- Development and Evaluation of Nanoemulgel Loaded with Minoxidil
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study
- Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis in Adult‐Onset Still's Disease: An Uncommon Initial Presentation in a Young Nepalese Female: A Case Report
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
- Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark
- Prescription Pattern of Tofacitinib for Alopecia Areata Among the Dermatologists in Saudi Arabia: A Cross-Sectional Study
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- Dupilumab treatment for atopic dermatitis leading to unexpected treatment for alopecia universalis
- Emerging Unconventional Therapies for Alopecia Areata
- Adult Kawasaki's disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Advances in the mechanism and new therapies of alopecia areata
- The Good and Bad News About New Drugs for Treating Alopecia Areata
- JAK inhibitors in dermatology: The promise of a new drug class
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Self-Organizing and Stochastic Behaviors During the Regeneration of Hair Stem Cells
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- Understanding autoimmunity of vitiligo and alopecia areata
- Vitiligo and alopecia areata: apples and oranges?
- Impaired Hair Follicle Morphogenesis and Cycling with Abnormal Epidermal Differentiation in nackt Mice, a Cathepsin L-Deficient Mutation
- Ethnopharmacological Significance of <i>Eclipta alba</i> (L.) Hassk. (Asteraceae)
- Alopecia Areata: Treatment of Today and Tomorrow
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata
- The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia
- Erosive pustular dermatosis (chronic atrophic dermatosis of the scalp and extremities)